Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Ademar de Mesquita BarbosaSelma Giorgio

Abstract

Chemotherapy for leishmaniosis a neglected parasitic disease, is based on few drugs, which are toxic and present resistance issues. Efforts for the development of new therapies are essential for the control of leishmaniasis. Metabolic pathway enzymes are promising targets for new drugs against parasites. The search for effective drugs against key enzymes can take advantage of the similarities between metabolic pathways in different microorganisms trypanosomatids Trypanosoma cruzi and Leishmania and fungus Saccharomyces cerevisiae. In this report, leishmanicidal activity of the metabolic pathway enzymes inhibitors (IDs) of dihydroorotate dehydrogenase (DHODH), glyceraldehyde 3-phosphate dehydrogenase and cruzain-cysteine protease from T. cruzi and scitalona-desidratase, adenosine deaminase, succinate dehydrogenase complex II and hydroxynaphthalene reductase from S. cerevisiae was performed on Leishmania amazonensis extracellular promastigotes and amastigotes within macrophages. The most promising compound, ID195, which is a DHODH inhibitor was toxic against promastigotes and was selective for amastigotes over host cells.

References

Jun 1, 1986·Molecular and Biochemical Parasitology·A K SahaA Bhaduri
Oct 1, 1995·Molecular and Biochemical Parasitology·R J Burchmore, D T Hart
Apr 23, 2002·Current Topics in Medicinal Chemistry·Faouzi Lakhdar-GhazalJacques Perie
Jul 17, 2003·Journal of Postgraduate Medicine·E Rosenthal, P Marty
Feb 16, 2005·Parasitology International·Wagner Weber Arrais-SilvaSelma Giorgio
Jun 25, 2005·Mini Reviews in Medicinal Chemistry·Adriano D Andricopulo, Carlos A Montanari
Nov 1, 2005·Lancet·Henry W MurrayNancy G Saravia
Apr 8, 2006·Protein Expression and Purification·Patrícia R FelicianoM Cristina Nonato
Oct 3, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Artur T CordeiroM Cristina Nonato
Apr 5, 2008·Parasitology Research·Dilvani O SantosHelena C Castro
Sep 3, 2009·The Korean Journal of Parasitology·Camila Bárbara Cantalupo LimaSelma Giorgio
Jul 8, 2010·Journal of Global Infectious Diseases·Susanne Nylén, Shalini Gautam
Oct 23, 2010·European Journal of Medicinal Chemistry·Juliana CheleskiCarlos A Montanari
Apr 27, 2011·Scandinavian Journal of Immunology·A DegrossoliS Giorgio
Sep 22, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S L Croft, P Olliaro
Feb 23, 2012·The Korean Journal of Parasitology·Solange dos Santos CostaSelma Giorgio
Nov 3, 2012·Current Pharmaceutical Design·Matheus Pinto PinheiroM Cristina Nonato
Mar 26, 2014·Current Topics in Medicinal Chemistry·E V CostaM M Pinto

❮ Previous
Next ❯

Citations

Jul 10, 2016·Asian Pacific Journal of Tropical Medicine·Marina Dal'Bó PelegriniSelma Giorgio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.